Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells

Oncogene

Volumn 25, Issue 45, 2006, Pages 6079-6091

  Hill, A ^a   McFarlane, S ^a   Mulligan, K ^a   Gillespie, H ^a   Draffin, J E ^a   Trimble, A ^a   Ouhtit, A ^a   Johnston, P G ^a   Harkin, D P ^a   McCormick, D ^a   Waugh, D J J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast cancer; CD44; Cortactin; Invasion; Metastasis

Indexed keywords

CORTACTIN; HERMES ANTIGEN; HYALURONIC ACID; I KAPPA B KINASE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN; TETRACYCLINE; TRANSCRIPTION FACTOR RELA;

ARTICLE; ATTENUATION; BONE MARROW CELL; BREAST CANCER; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; PHARMACOLOGICAL BLOCKING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA INTERFERENCE;

ANTIGENS, CD44; BASE SEQUENCE; BLOTTING, WESTERN; BONE MARROW; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CORTACTIN; DNA PRIMERS; ENDOTHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 33749853670     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209628     Document Type: Article

References (39)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Proc Natl Acad Sci U S A 100: 3983-3988.
2. Arderiu G, Diaz-Ricart M, Buckley B, Escolar G, Ordinas A. (2002). Biochem J 364: 65-71.
3. Auvinen P, Tammi R, Parkinnen J, Tammi M, Agren U, Johansson R et al. (2000). Am J Pathol 156: 529-536.
4. Berner HS, Nesland JM. (2001). Breast Cancer Res Treat 65: 23-29.
5. Bourguignon LYW, Gunja-Smith N, Iida N, Zhu HB, Young LJ, Muller WJ et al. (1998). J Cell Physiol 176: 206-215.
6. Bourguignon LYW, Singleton PA, Diedrich F. (2004). J Biol Chem 279: 29654-29669.
7. Bourguignon LYW, Zhu H, Shao L, Chen YW. (2000). J Biol Chem 275: 1829-1838.
8. Bourguignon LYW, Zhu H, Shao L, Chen YW. (2001). J Biol Chem 276: 7327-7336.
9. Bourguignon LYW, Zhu H, Shao L, Zhu D, Chen YW. (1999). Cell Motil Cytoskeleton 43: 269-287.
10. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. (1999). Oncogene 18: 4440-4449.
11. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, Weaver AM. (2005). Curr Biol 15: 1276-1285.
12. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJJ. (2004). Cancer Res 64: 5702-5711.
13. Fitzgerald KA, Bowie AG, Sheehy-Skeffington B, O'Neill LAJ. (2000). J Immunol 164: 2053-2063.
14. Herrera-Gayol A, Jothy S. (2001). Int J Exp Pathol 82: 193-200.
15. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T et al. (1996). J Cell Biol 135: 37-51.
16. Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA et al. (1997). Oncogene 15: 1617-1623.
17. Isacke CM, Yarwood H. (2002). Int J Biochem & Cell Biol 34: 718-721.
18. Kinoshita J, Haga S, Shimizu T, Imamura H, Watanabe O, Kajiwara T. (2000). Breast Cancer Res Treat 53: 177-183.
19. Kozlow W, Guise TA. (2005). J Mammary Gland Biol Neoplasia 10: 169-180.
20. Lee JY, Spicer AP. (2000). Curr Opin Cell Biol 12: 581-586.
21. Lester BR, McCarthy JB. (1992). Cancer Metastasis Rev 11: 31-44.
22. Li Y, Tondravi M, Lui J, Smith E, Haudenschild CC, Kaczmarek M et al. (2001). Cancer Res 61: 6906-6911.
23. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C et al. (1996). J Clin Invest 98: 2403-2413.
24. Monaghan M, Mulligan K, Gillespie H, Trimble A, Winter P, Johnston PG et al. (2000). J Pathol 192: 519-525.
25. Mullins RD. (2000). Curr Opin Cell Biol 12: 91-96.
26. Oliferenko S, Kaverina I, Small JV, Huber LA. (2000). J Cell Biol 148: 1159-1164.
27. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C. (2000). Clin Cancer Res 6: 3177-3182.
28. Sayegh TY, Arora PD, Fan L, Laschinger CA, Greer PA, McCulloch CA et al. (2005). Mol Biol Cell 12: 5514-5527.
29. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. (1992). Oncogene 7: 355-361.
30. Tilghman RW, Hoover RL. (2002). FASEB J 16: 1257-1259.
31. Timpson P, Lynch DK, Schramek D, Walker F, Daly RJ. (2005). Cancer Res 65: 3273-3280.
32. Toole BP. (2000). Glycobiology 12: 37R-42R.
33. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. (1994). J Cell Biol 126: 391-401.
34. Urono T, Lui J, Zhang P, Fan YX, Egile C, Li R et al. (2001). Nat Cell Biol 3: 259-266.
35. Van Rossum AG, Gibcus J, van der Wal J, Schuuring E. (2005). Breast Cancer Res 7: 235-237.
36. Weaver AM, Karginov AV, Kinley AW, Weed SA, Li Y, Parsons JT et al. (2001). Curr Biol 11: 370-374.
37. Weber GF, Bronson RT, Ilagan J, Cantor H, Schmits R, Mak TW. (2002). Cancer Res 62: 2281-2286.
38. Yamaguchi H, Wyckoff J, Condeelis J. (2005). Curr Opin Cell Biol 17: 559-564.
39. Zhu D, Bourguignon LYW. (1998). Cell Motil Cytoskel 39: 209-222.